Premium
IPILIMUMAB PLUS LENALIDOMIDE FOR TREATMENT OF RELAPSED DISEASE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION (AlloSCT) IN PATIENTS (PTS) WITH LYMPHOID MALIGNANCIES
Author(s) -
Khouri I.F.,
Milton D.R.,
Nicholas C.,
Jabbour E.,
Singh S.,
Vence L.,
Allison J.P.,
Gulbis A.M.,
Sharma P.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.124_2630
Subject(s) - medicine , lenalidomide , transplantation , mantle cell lymphoma , multiple myeloma , progressive disease , gastroenterology , ipilimumab , surgery , follicular lymphoma , lymphoma , oncology , chemotherapy , immunotherapy , cancer
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom